JMI LABS IS NOW PART OF LEARN MORE

Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: A global surveillance report (2003-2004). by Watters AA, Jones RN, Leeds JA, Denys G, Sader HS and Fritsche TR published in J. Antimicrob. Chemother. 2006; 57 (5): 914-923

View on Pubmed